CTX-M ESBL enzyme in Escherichia coli from urology patients in Rawalpindi, Pakistan

Journal of the Pakistan Medical Association

Volumn 56, Issue 12, 2006, Pages 576-578

  Mirza, Sajjad Hussain ^a   Salman, Muhammad ^b   Khurshid, Umar ^a   Wiqar, M Amin ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (Pakistan)

^b NATIONAL INSTITUTE OF HEALTH   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DOXYCYCLINE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; BETA LACTAMASE; BETA LACTAMASE TEM 3; BETA-LACTAMASE TEM-3; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; CONTROLLED STUDY; ENZYME SYNTHESIS; ESCHERICHIA COLI; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PAKISTAN; PHENOTYPE; TERTIARY HEALTH CARE; TEST STRIP; URINALYSIS; ENZYMOLOGY; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIOLOGY; URINARY TRACT DISEASE; URINE;

BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; HOSPITALS; HUMANS; PAKISTAN; PHENOTYPE; UROLOGIC DISEASES;

EID: 34247104502     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Woodward N, Ward ME, Kaufmann ME. Turton J, Tagan EJ, James D, et al. Community and hospital spread of Escherichia coli producing CTX-M extended spectrum β-lactam in the UK. J Antimicrob Chemother 2004; 54: 735-43.
2. Knothe H, Shah P, Krcmery V, Antal M, Mitsubashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcesens. Infection1983;11:315- 17.
3. Kliebe C, Nies BA, Meyer JF, Tolxdorf-Neutzling RM, Wiedermann B. Evolution of plasmid-coded resistance to broad-spectrumcephalosporins. Antimicrob Agents Chemother 1985; 28: 302-7.
4. Sturenburg E, Lang M, Horstkotte MA, Laufs R, Mack D. Evaluation of Microscan ESBL plus confirmation panel for detection of extended-spectrum β-lactamases in clinical isolates of oxyimino-cephalosporin resistant gram-negative bacteria. J Antimicrob Chemother 2004;54:870-5
5. Livermore DM, Hawkey PM. CTX-M: Changing the face of ESBLs in the UK. J Antimicrob Chemotherapy 2005;56:451-4.
6. Wyllie DH, Baxter E, Morgan M, Bowller TC. Spread of multiresistance and extended-spectrum β-lactamases amongst urinary Escherichia coli in Oxford, UK. J Antimicrob Chemotherapy 2005;56:986-8.
7. Jabeen K, Zafar A, Hasan R. Comparison of double disc and combined disc method for the detection of extended spectrum beta lactamses in enterobacteriacae. J Pak Med Assoc 2003; 53: 534-6.
8. Shah AA, Hasan F, Ahmed S, Hameed A. Prevalence of extended spectrum beta lactamses in nosocomial and outpatients (Ambulatory). Pak J Med Sci 2002; 25:363-6.
9. BSAC Disc Diffusion Method for Antimicrobial Susceptibility Testing. Version 4 2005.
10. Performance standards for antimicrobial susceptibility testing; Fourteenth Informational Supplement (M100-S14) 2004. Wayne PA National Committee for Clinical Laboratories.
11. Jacoby GA, Price LSM. The new beta lactamases. N Eng J Med. 2005;352: 380-91.
12. Costa D, Poeta P, Brinas L, Saenz Y, Rodrigues J, Torres C. Detection of CTXM-1 and TEM-52 β-lactamases in Escherichia coli strains from healthy pets in Portugal. J Antimicrob Chemother. 2004; 54: 960-1.
13. Baraniak A, Fiett J, Hrynicwicz W, Nordmann P, Gniadkowski M. Ceftizidime hydrolyzing CTX-M15 extended spectrum β-lactamases (ESBLs) in Poland. J Antimicrob Chemother 2003;50:393-6.
14. Samaha Kfoury JNS, Araj GF. Recent developments in beta lactamases and extended spectrum beta lactamases. B Med J. 2003; 327:1209-13.
15. Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriacae producing extended spectrum beta lactamases (ESBLs) in the community. Journal of Antimicrob Chemotherapy 2005; 56:52-9.
16. Bradford PA. extended spectrum beta-lactamses in the 21st century: Characterization , epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001; 14:933-51.
17. Sirot D. Extended-spectrum plasmid-mediated b-lactamases. J Antimicrob Chemother 1995; 36 (Suppl A): 19-34.
18. Sturenburg E, Sobottka I, Noor D, Laufs R, Mack D. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum b-lactamases in an Enterobacteriaceae strain collection. J Antimicob Chemother 2004; 54:134-8.
19. Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum b-lactamases. J Antimicrob Chemother Advance Access pub 2006; 57:154-5.